FindTrial
Sign In

Evaluation of active dichoptic therapy

EVALUATION OF DICHOPTIC BASED THERAPY IN CASES OF ANISOMETROPIC AMBLYOPIA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054200
Enrollment
60
Registered
2023-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: H523- Anisometropia and aniseikonia

Interventions

Intervention1: ACTIVE DICHOPTIC THERAPY: GROUP OF 30 PATIENTS IN WHICH ACTIVE DICHOPTIC THERAPY WILL BE GIVEN PARAMETERS CHECKED AT BASELINE , 3 MONTHS AND 6 MONTHS Control Intervention1: OCCLUSION

Sponsors

DR RAJENDRA PRASAD CENTRE FOR OPHTHALMIC SCIENCES , AIIMS NEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.MILD TO MODERATE CASES OF ANISOMETROPIC AMBLYOPIA GIVING CONSENT FOR STUDY AND FOLLOW UP 2.AVAILABILITY OF LAPTOP / TABLET AT HOME 3.NOT UNDERGONE ANY TREATMENT FOR AMBLYOPIA EXCEPT SPECTACLES USE

Exclusion criteria

Exclusion criteria: 1.SEVERE AMBLYOPIA 2.STRABISMIC OR AMETROPIC OR MIXED AMBLYOPIA 3.MYOPIA >6D 4.OTHER CAUSES OF VISION LOSS 5.UNDERGONE OCULAR SURGERY IN LAST 6 MONTHS 6.NOT GIVING CONSENT FOR STUDY

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE VISUAL OUTCOME OF ARTIFICIAL INTELLIGENCE BASED ACTIVE DICHOPTIC THERAPY VERSUS A STANDARD MONOCULAR TREATMENT METHOD i.e., OCCLUSIONTimepoint: TO COMPARE THE VISUAL OUTCOME OF ARTIFICIAL INTELLIGENCE BASED ACTIVE DICHOPTIC THERAPY VERSUS A STANDARD MONOCULAR TREATMENT METHOD i.e., OCCLUSION—

Secondary

MeasureTime frame
TO EVALUATE THE COMPLIANCE IN TWO GROUPSTimepoint: 0 MONTHS , 3 MONTHS , 6 MONTHS—

Countries

India

Contacts

Public ContactDr Nisha Yadav

DR RAJENDRA PRASAD CENTRE FOR OPHTHALMIC SCIENCES , AIIMS NEW DELHI

drmsswati@rediffmail.com9810685898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026